arrow
A

August Vidal

university hospital o bellvitge
H指数:53
被引数:9,229

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromatin activity of IκBα mediates the exit from naive pluripotency
2025-10-220
PRE
Specific targeting of the pseudogene RPSAP52 reduces ovarian tumor growth in patient-derived orthoxenograft models

特异性靶向假基因RPSAP52可降低患者来源的正向移植物模型中的卵巢肿瘤生长

2025-10-030
PRE
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024-03-266
OAAI
S1PR1 directs tumorsphere proliferation in ovarian cancer
2024-03-220
PRE
Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer
2023-08-014
OAAI
Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome

子宫内膜抽吸物中高度敏感的微卫星不稳定性和免疫组织化学评估作为Lynch综合征癌症风险个体化的工具

2023-07-013
PRE
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

肿瘤反应性CD4和CD8 til的生物标志物与子宫内膜癌预后改善相关。

2022-12-2922
OAAI
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness

氧化应激诱导的FAK激活有助于子宫浆液性癌的侵袭性

2022-12-0711
OA
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
2022-11-143
OAAI
An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study
2022-06-299
OA
Night work, chronotype and risk of endometrial cancer in the Screenwide case-control study
2022-02-249
PRE
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma
2021-09-2913
OA